Dole plc

DOLE

CIK 0001857475 · Quarterly mode · latest period FY2025 (Q3) (ending 2025-09-30) · sourced from SEC EDGAR

At a glance · FY2025 (Q3)

Revenue
$2.28B
↑+10.5% +$217Mvs FY2024 (Q3)
Operating Income
$24M
↓-49.4% -$24Mvs FY2024 (Q3)
Net Income
$5M
↓-64.6% -$9Mvs FY2024 (Q3)
Gross Profit
$155M
↓-5.4% -$9Mvs FY2024 (Q3)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
46/100
  • Profitability
    5ROIC 5.9% (10% = solid, 20%+ = moat)
  • Liquidity
    34Current Ratio 1.17 (above 1.5 = solid)
  • Leverage
    70D/E 0.61 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 2.07x (1.0+ = capital-efficient)
  • Growth
    41Revenue YoY +7.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    23Op Margin 1.1% · trend -1.6pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project DOLE's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$0.31
Total enterprise IV
$29M
Diluted shares
0.10B
Terminal PV
$21M (72% of total)
Year-5 FCF
$3M
YearProjected FCFDiscounted PV
+1$2M$2M
+2$2M$2M
+3$2M$2M
+4$2M$2M
+5$3M$2M
Terminal$34M$21M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$53M
investment in PP&E
Dividends paid (TTM)
$32M
cash returned to holders
Stock-based comp (TTM)
$1M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$4.40B
everything owned
Total liabilities
$2.89B
everything owed
Stockholders' equity
$1.36B
shareholder claim
Net debt
$562M
LT debt minus cash

Recent performance · 13 quarters

Revenue↑+7.3% +$155M
$2.28B
Net Income↓-93.6% -$75M
$5M
Free Cash Flow
$-132M
Operating Margin↓-3.0pts
1.1%

Drill down